Hostname: page-component-586b7cd67f-rdxmf Total loading time: 0 Render date: 2024-11-25T00:34:48.484Z Has data issue: false hasContentIssue false

A Survey of Infection Prevention and Control Practices among Hematopoietic Stem Cell Transplant Centers

Published online by Cambridge University Press:  07 December 2015

Elena Beam*
Affiliation:
Division of Infectious Diseases, Mayo Clinic, Rochester, Minnesota
Michael R. Keating
Affiliation:
Division of Infectious Diseases, Mayo Clinic, Rochester, Minnesota The William J von Liebig Center for Transplantation and Clinical Regeneration, Mayo Clinic, Rochester, Minnesota
Raymund R. Razonable*
Affiliation:
Division of Infectious Diseases, Mayo Clinic, Rochester, Minnesota The William J von Liebig Center for Transplantation and Clinical Regeneration, Mayo Clinic, Rochester, Minnesota
*
Address correspondence to Elena Beam, MD, Mayo Clinic, Infectious Disease, 200 First Street SW, Rochester, MN 55905 ([email protected]) or Raymund Razonable, MD Mayo Clinic, Infectious Disease, 200 First Street SW, Rochester, MN 55905 ([email protected]).
Address correspondence to Elena Beam, MD, Mayo Clinic, Infectious Disease, 200 First Street SW, Rochester, MN 55905 ([email protected]) or Raymund Razonable, MD Mayo Clinic, Infectious Disease, 200 First Street SW, Rochester, MN 55905 ([email protected]).

Abstract

This survey of the American Society of Transplantation Infectious Disease Community of Practice demonstrates variations in clinical practices among hematopoietic stem cell transplant centers on selected infection prevention and control practices. Our findings highlight a need and emphasize an opportunity to optimize patient care through standardization of practices in this vulnerable population.

Infect. Control Hosp. Epidemiol. 2016;37(3):348–351

Type
Concise Communications
Copyright
© 2015 by The Society for Healthcare Epidemiology of America. All rights reserved 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

REFERENCES

1. Pasquini, MC, Zhu, X. Current use and outcome of hematopoietic stem cell transplantation: CIBMTR Summary Slides, 2014. Center for International Blood and Transplant Research website. http://www.cibmtr.org/ReferenceCenter/SlidesReports/SummarySlides/pages/index.aspx Published 2014. Accessed September 11, 2015.Google Scholar
2. Piret, J, Boivin, G. Antiviral drug resistance in herpesviruses other than cytomegalovirus. Rev Med Virol 2014;24:186218.CrossRefGoogle ScholarPubMed
3. Bock, AM, Cao, Q, Ferrieri, P, Young, JA, Weisdorf, DJ. Bacteremia in blood or marrow transplantation patients: clinical risk factors for infection and emerging antibiotic resistance. Biol Blood Marrow Transpl 2013;19:102108.CrossRefGoogle ScholarPubMed
4. Trifilio, S, Singhal, S, Williams, S, et al. Breakthrough fungal infections after allogeneic hematopoietic stem cell transplantation in patients on prophylactic voriconazole. Bone Marrow Transpl 2007;40:451456.Google Scholar
5. McCann, S, Byrne, JL, Rovira, M, et al. Outbreaks of infectious diseases in stem cell transplant units: a silent cause of death for patients and transplant programmes. Bone Marrow Transpl 2004;33:519529.Google Scholar
6. Kruger, WH, Hornung, RJ, Hertenstein, B, et al. Practices of infectious disease prevention and management during hematopoietic stem cell transplantation: a survey from the European group for blood and marrow transplantation. J Hematother Stem Cell Res 2001;10:895903.Google Scholar
7. Hicheri, Y, Einsele, H, Martino, R, Cesaro, S, Ljungman, P, Cordonnier, C. Environmental prevention of infection in stem cell transplant recipients: a survey of the Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation. Transpl Infect Dis 2013;15:251258.CrossRefGoogle ScholarPubMed
8. Yokoe, D, Casper, C, Dubberke, E, et al. Infection prevention and control in health-care facilities in which hematopoietic cell transplant recipients are treated. Bone Marrow Transpl 2009;44:495507.CrossRefGoogle ScholarPubMed
9. Tomblyn, M, Chiller, T, Einsele, H, et al. Guidelines for preventing infectious complications among hematopoietic cell transplantation recipients: a global perspective. Biol Blood Marrow Transpl 2009;15:11431238.Google Scholar
10. Tomblyn, M, Chiller, T, Einsele, H, et al. Guidelines for preventing infectious complications among hematopoietic cell transplant recipients: a global perspective. Preface. Bone Marrow Transpl 2009;44:453455.CrossRefGoogle ScholarPubMed